# Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)

Study · id `cardio:ct-nct04863664` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04863664](<https://clinicaltrials.gov/study/NCT04863664>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04863664

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1007 participants.

## Technical summary

Registry record NCT04863664. Non-randomized; no masking; primary purpose treatment. Start 2021-06-21 (actual); primary completion 2025-09-03 (actual). Results posted on 2026-11-04.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1007 participants (enrolled count; ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Started: 2021-06-21 (actual) (ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2025-09-03 (actual) (ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Completion: 2025-11-06 (actual) (ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Results first posted: 2026-11-04 (ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Countries: United States; Australia; Austria; Belgium; Canada; China; Denmark; France; Germany; Hong Kong SAR China; Italy; Japan; Malaysia; Netherlands; Poland; Portugal; Serbia; Singapore; Spain; United Kingdom (ClinicalTrials.gov record NCT04863664, source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04863664-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)
- Condition: Ventricular Tachyarrhythmia
- Intervention (Device): Defibrillation (RV Implant)
- Intervention (Device): Defibrillation (LBBAP Implant)
- Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- Registry lists this organization as the lead sponsor: Medtronic Cardiac Rhythm and Heart Failure (`cardio:org-medtronic-cardiac-rhythm-and-heart-failure`)

## Provenance

Content hash: d19e7a5debe79e85301e7f5d0be5aa780192d5338007c65053f97fa6b52bdb4a
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
